Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080493551> ?p ?o ?g. }
- W2080493551 endingPage "299" @default.
- W2080493551 startingPage "293" @default.
- W2080493551 abstract "Cyclophosphamide induces a severe haemorrhagic cystitis characterized by bladder overactivity. The study was conducted to examine effects of a phosphodiesterase 4 (PDE4) inhibitor rolipram on bladder overactivity in rats with cyclophosphamide treatment. 42 female Wistar rats were used. 30 rats received a single i.p. injection of cyclophosphamide, and after 72 h, bladder function was evaluated by (1) in vitro preparations of whole bladders and (2) cystometry with continuous saline infusion under urethane anesthesia. Cyclophosphamide-treatment dramatically potentiated the basal spontaneous contractions of isolated whole bladders compared to control rats. Atropine, guanethidine or suramin was ineffective on the spontaneous contractions whereas nifedipine completely abolished. Rolipram (5-80 microM) induced a significant concentration-dependent decrease on the amplitude, frequency (contractions/min) and area under the curve of spontaneous contractions. Carbachol elicited phasic contractions superimposed on a tonic contraction. Rolipram caused a relaxation on the tonic contraction whereas it could not affect the phasic contractions induced by carbachol. In anesthetized rats, during continuous infusion cystometry, intercontraction interval was significantly shorter in cyclophosphamide-injected rats than in control rats. Rolipram at 5-40 microM has no significant effect on the intercontraction interval and contraction pressure while it significantly decreased pressure threshold. At 80 microM, it significantly decreased the intercontraction interval and contraction pressure. In conclusion, PDE4 inhibitor rolipram caused a significant decrease on the amplitude, frequency and area under the curve of basal spontaneous contractions in cyclophosphamide-treated rats, at doses that have no effect on the carbachol-induced phasic contractions and cystometric parameters. PDE4 inhibitors may be considered as an attractive strategy for the treatment of cyclophosphamide-induced bladder overactivity." @default.
- W2080493551 created "2016-06-24" @default.
- W2080493551 creator A5014675098 @default.
- W2080493551 creator A5037561231 @default.
- W2080493551 creator A5055457842 @default.
- W2080493551 creator A5079495242 @default.
- W2080493551 date "2008-05-01" @default.
- W2080493551 modified "2023-09-26" @default.
- W2080493551 title "Effect of phosphodiesterase type 4 inhibitor rolipram on cyclophosphamide-induced cystitis in rats" @default.
- W2080493551 cites W1256336268 @default.
- W2080493551 cites W183891664 @default.
- W2080493551 cites W1970761712 @default.
- W2080493551 cites W1970847023 @default.
- W2080493551 cites W1973431724 @default.
- W2080493551 cites W1974849697 @default.
- W2080493551 cites W1975391576 @default.
- W2080493551 cites W1984510719 @default.
- W2080493551 cites W1986516357 @default.
- W2080493551 cites W1987075214 @default.
- W2080493551 cites W1988329889 @default.
- W2080493551 cites W1989542911 @default.
- W2080493551 cites W2021487574 @default.
- W2080493551 cites W2023939859 @default.
- W2080493551 cites W2025824319 @default.
- W2080493551 cites W2044092388 @default.
- W2080493551 cites W2050055410 @default.
- W2080493551 cites W2060644543 @default.
- W2080493551 cites W2062165288 @default.
- W2080493551 cites W2066240382 @default.
- W2080493551 cites W2077080697 @default.
- W2080493551 cites W2078563272 @default.
- W2080493551 cites W2095068093 @default.
- W2080493551 cites W2119241398 @default.
- W2080493551 cites W2123623552 @default.
- W2080493551 cites W2129885324 @default.
- W2080493551 cites W2790166127 @default.
- W2080493551 doi "https://doi.org/10.1016/j.ejphar.2008.02.022" @default.
- W2080493551 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18358472" @default.
- W2080493551 hasPublicationYear "2008" @default.
- W2080493551 type Work @default.
- W2080493551 sameAs 2080493551 @default.
- W2080493551 citedByCount "15" @default.
- W2080493551 countsByYear W20804935512012 @default.
- W2080493551 countsByYear W20804935512013 @default.
- W2080493551 countsByYear W20804935512014 @default.
- W2080493551 countsByYear W20804935512015 @default.
- W2080493551 countsByYear W20804935512016 @default.
- W2080493551 countsByYear W20804935512018 @default.
- W2080493551 countsByYear W20804935512019 @default.
- W2080493551 countsByYear W20804935512020 @default.
- W2080493551 countsByYear W20804935512021 @default.
- W2080493551 countsByYear W20804935512023 @default.
- W2080493551 crossrefType "journal-article" @default.
- W2080493551 hasAuthorship W2080493551A5014675098 @default.
- W2080493551 hasAuthorship W2080493551A5037561231 @default.
- W2080493551 hasAuthorship W2080493551A5055457842 @default.
- W2080493551 hasAuthorship W2080493551A5079495242 @default.
- W2080493551 hasConcept C126322002 @default.
- W2080493551 hasConcept C134018914 @default.
- W2080493551 hasConcept C163415756 @default.
- W2080493551 hasConcept C181199279 @default.
- W2080493551 hasConcept C185592680 @default.
- W2080493551 hasConcept C24998067 @default.
- W2080493551 hasConcept C2776694085 @default.
- W2080493551 hasConcept C2776755627 @default.
- W2080493551 hasConcept C2776958096 @default.
- W2080493551 hasConcept C2778988552 @default.
- W2080493551 hasConcept C2779762690 @default.
- W2080493551 hasConcept C2780080261 @default.
- W2080493551 hasConcept C55493867 @default.
- W2080493551 hasConcept C62826618 @default.
- W2080493551 hasConcept C71924100 @default.
- W2080493551 hasConcept C98274493 @default.
- W2080493551 hasConceptScore W2080493551C126322002 @default.
- W2080493551 hasConceptScore W2080493551C134018914 @default.
- W2080493551 hasConceptScore W2080493551C163415756 @default.
- W2080493551 hasConceptScore W2080493551C181199279 @default.
- W2080493551 hasConceptScore W2080493551C185592680 @default.
- W2080493551 hasConceptScore W2080493551C24998067 @default.
- W2080493551 hasConceptScore W2080493551C2776694085 @default.
- W2080493551 hasConceptScore W2080493551C2776755627 @default.
- W2080493551 hasConceptScore W2080493551C2776958096 @default.
- W2080493551 hasConceptScore W2080493551C2778988552 @default.
- W2080493551 hasConceptScore W2080493551C2779762690 @default.
- W2080493551 hasConceptScore W2080493551C2780080261 @default.
- W2080493551 hasConceptScore W2080493551C55493867 @default.
- W2080493551 hasConceptScore W2080493551C62826618 @default.
- W2080493551 hasConceptScore W2080493551C71924100 @default.
- W2080493551 hasConceptScore W2080493551C98274493 @default.
- W2080493551 hasIssue "1-3" @default.
- W2080493551 hasLocation W20804935511 @default.
- W2080493551 hasLocation W20804935512 @default.
- W2080493551 hasOpenAccess W2080493551 @default.
- W2080493551 hasPrimaryLocation W20804935511 @default.
- W2080493551 hasRelatedWork W1901275661 @default.
- W2080493551 hasRelatedWork W1976707393 @default.
- W2080493551 hasRelatedWork W1986343589 @default.
- W2080493551 hasRelatedWork W2034768996 @default.